Clinical Trial Supplies Market
Clinical Trial Supplies Market Size, Share And Industry Analysis Report By Services (Logistics, Distribution, Storage, Retention, Packaging, Labeling, Blinding, Manufacturing And Comparator Sourcing); By Phases (Phase 1, Phase 2, Phase 3, Phase 4 AND BA/ BE studies); By Type (Small Molecules, Biologics and Medical devices); By Therapeutic Areas (Oncology, CNS and mental disorders, Cardiovascular diseases, Digestive disorders, Infectious diseases, Metabolic disorders, Immunology and Blood disorders); By End User (Pharma, Biotech, Academia, Investigators, Regulators, Ethics/IRBs, Participants, Data/Tech, Logistics and CROs) - Forecast Year 2024 – 2031
Healthcare // Analytical & Scientific Instrumentation
The global Clinical Trial Supplies market is
foreseen to grow by 10.1%, from USD 3.37 Billion in 2022 to USD 7.28 Billion in
2030. increasing R&D expenditure of pharmaceutical and biopharmaceutical
companies, increasing number of registered clinical trials, increasing
decentralization of clinical trials is to drive the market for the upcoming
forecast period. However, high cost of drug development remains one factor
hindering the market growth over the anticipated period.
Market Definition
What Is Clinical Trial Supplies?
Market Overview
Market Segmentation
For the purpose of this report, the global clinical
trial supplies market segmented on the basis of services, phase, type, therapeutic
area end user, and region:
Services Outlook:
On the basis of services, the market is
segmented into logistics & distribution, storage & retention,
packaging, labeling, and blinding, manufacturing, comparator sourcing, other
services (solutions, ancillary supply).
Phase Outlook:
On the basis of phase, the market is
segmented into phase 1, phase 2, phase 3, phase 4, ba/ be studies.
Type Outlook:
On the basis of type, the market is segmented
into small-molecules, biologic drugs, medical devices.
Therapeutic Area Outlook:
On the basis of therapeutic area, the market
is segmented into oncology, cns and mental disorders, cardiovascular diseases,
digestive disorders, infectious diseases, metabolic disorders, immunology,
blood disorders other therapeutic areas.
End User Outlook:
On the basis of end user, the market is
segmented into pharmaceutical & biotechnology companies, contract research
organizations (CROs), medical devices companies, academia, investigators,
regulators, ethics/IRBS, participants data/tech, logistics.
Figure 1 Clinical Trial Supplies Market By End User (Market Size And
Forecast By Value - USD Million, 2022 & 2030)
Regional Outlook (Revenue, USD Million; 2022 & 2030)
|
Regional Outlook (Revenue, USD Million; 2020-2030) |
|
|
North America |
U.S. |
|
Canada |
|
|
Europe |
Germany |
|
U.K. |
|
|
France |
|
|
Spain |
|
|
Italy |
|
|
Rest of the Europe |
|
|
Asia Pacific |
India |
|
Japan |
|
|
China |
|
|
South Korea |
|
|
Australia |
|
|
Rest of Asia-Pacific |
|
|
Middle East & Africa |
UAE |
|
Saudi Arabia |
|
|
South Africa |
|
|
Rest of Middle East &
Africa |
|
|
Latin America |
Brazil |
|
Mexico |
|
|
Argentina |
|
|
Rest of Latin America |
|
Figure 2 Clinical Trial Supplies Market: Regional Dynamics
Companies Considered And Profiled In This Market Study
The players operating in the market have
undertaken several strategies related to the market in the period 2020-2022.
some of the prominent players in the clinical trial supplies market include
·
ACNOS PHARMA GMBH
·
ADALLEN PHARMA
·
ALMAC GROUP
·
ANCILLARE, LP
·
BIOCAIR
·
CAPSUGEL (ACQUIRED
BY LONZA)
·
CATALENT, INC.
·
CLINICAL SERVICES
INTERNATIONAL
·
CLINIGEN LIMITED
·
COREX LOGISTICS
·
CT GROUP LLC
·
DURBIN
·
EUROFINS SCIENTIFIC
·
INFOSYS
·
KLIFO
·
LIVEO RESEARCH
·
MARKEN (SUBSIDIARY
OF UPS)
·
MOVIANTO
·
N-SIDE
·
PAREXEL
INTERNATIONAL CORPORATION
·
PCI PHARMA SERVICES
·
PIRAMAL PHARMA SOLUTIONS
·
PRA HEALTH SCIENCES
(SUBSIDIARY OF ICON PLC)
·
RECIPHARM AB
·
THERMO FISHER
SCIENTIFIC
Global Clinical Trial Supplies Market Report Scope
|
Historical data |
2020 - 2022 |
|
Base year for estimation |
2022 |
|
Forecast period |
2023 - 2030 |
|
Market size value in 2022 |
USD 3.37 Billion |
|
Revenue forecast in 2030 |
USD 7.28 Billion |
|
Growth Rate |
CAGR of 10.1% from 2023 to 2030 |
|
Quantitative units |
Revenue in USD Million/Billion & CAGR from 2023 to 2030 |
|
Report coverage |
Revenue forecast, company share, competitive
landscape, growth factors, and trends |
|
Segments covered |
Services, Phase, Type, Therapeutic Area End User |
|
Key companies profiled |
Thermo Fisher Scientific, Catalent, Inc., Marken
(Subsidiary of Ups) |
|
Regional Scope |
North America, Europe, Asia Pacific, Middle East & Africa, Latin
America |
|
Country Scope |
U.S., Canada, Germany, U.K., France, Italy,
Spain, India, Japan, China, Australia, South Korea, Saudi Arabia, UAE, South
Africa, Brazil, Mexico, Argentina |
|
Customization scope |
Free report customization (equivalent to up to 8 analysts’ working
days) with purchase. Addition or alteration to country, regional &
segment scope. |
Services Outlook (Revenue,
USD Million/Billion; 2020-2030)
·
Logistics &
distribution
·
Storage & retention
·
Packaging,
labeling, and blinding
·
Manufacturing
·
Comparator sourcing
·
Other services
(solutions, ancillary supply)
Phase Outlook (Revenue,
USD Million/Billion; 2020-2030)
·
Phase 1
·
Phase 2
·
Phase 3
·
Phase 4
·
BA/ BE studies
Type Outlook
(Revenue, USD Million/Billion; 2020-2030)
·
Small-molecules
·
Biologic drugs
·
Medical devices
Therapeutic Area Outlook
(Revenue, USD Million/Billion; 2020-2030)
·
Oncology
·
CNS and mental
disorders
·
Cardiovascular
diseases
·
Digestive disorders
·
Infectious diseases
·
Metabolic disorders
·
Immunology
·
Blood disorders
·
Other therapeutic
areas
End User Outlook
(Revenue, USD Million/Billion; 2020-2030)
·
Pharmaceutical
& Biotechnology companies
·
Contract Research
Organizations (CROs)
·
Medical Devices Companies
·
Academia
·
Investigators
·
Regulators
·
Ethics/IRBs
·
Participants
·
Data/Tech
·
Logistics
Regional Outlook (Revenue,
USD Million/Billion; 2020-2030)
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
U.K.
o
France
o
Spain
o
Italy
o
Rest of the Europe
·
Asia Pacific
o
India
o
Japan
o
China
o
South Korea
o
Australia
o
Rest of
Asia-Pacific
·
Middle East &
Africa
o
UAE
o
Saudi Arabia
o
South Africa
o
Rest of Middle East
& Africa
·
Latin America
o
Brazil
o
Mexico
o
Argentina
o
Rest of Latin
America
Recent Developments In Clinical Trial Supplies Market:
|
Chapter
1. Introduction |
|
|
1.1. Market Definition |
|
|
1.2. Research Scope |
|
|
1.2.1. Markets Covered |
|
|
1.2.2. Years Considered for
Study |
|
|
Chapter
2. Executive Summary |
|
|
2.1. Summary Snapshot Market Size
and Forecast, 2020-2030 |
|
|
2.2. Clinical Trial Supplies Market
Share by Services, 2022 vs 2030 (USD Million) |
|
|
2.3. Clinical Trial Supplies Market
Share by Phase, 2022 vs 2030 (USD Million) |
|
|
2.4. Clinical Trial Supplies Market
Share by Type, 2022 vs 2030 (USD Million) |
|
|
2.5. Clinical Trial Supplies Market
Share by Therapeutic Area, 2022 vs 2030 (USD Million) |
|
|
2.6. Clinical Trial Supplies Market
Share by End User, 2022 vs 2030 (USD Million) |
|
|
2.7. Clinical Trial Supplies Market
Share by Region, 2022 vs 2030 (USD Million) |
|
|
Chapter
3. Key Insights |
|
|
Chapter
4. Clinical Trial Supplies Market Segmentation & Impact Analysis |
|
|
4.1. Clinical Trial Supplies Market
Indicators Analysis |
|
|
4.1.1. Market Drivers
Analysis |
|
|
4.1.1.1. Increasing
R&D expenditure of pharmaceutical and biopharmaceutical companies |
|
|
4.1.1.2. Increasing
number of registered clinical trials |
|
|
4.1.1.3. Increasing
decentralization of clinical trials |
|
|
4.1.2. Market Restraint
Analysis |
|
|
4.1.2.1. High cost
of drug development |
|
|
4.1.3. Market Opportunity
Analysis |
|
|
4.1.3.1. Emerging
markets |
|
|
4.2. Regulatory Analysis |
|
|
4.2.1. North America |
|
|
4.2.1.1. U.S. |
|
|
4.2.1.2. Canada |
|
|
4.2.2. Europe |
|
|
4.2.3. Asia Pacific |
|
|
4.2.3.1. India |
|
|
4.2.3.2. Japan |
|
|
4.2.3.3. China |
|
|
4.3. Technological Insights |
|
|
4.4. COVID-19 Impact analysis on
Clinical Trial Supplies Market |
|
|
4.5. Porter’s Five Forces Analysis |
|
|
4.5.1. Bargaining Power of
Buyers/Consumers |
|
|
4.5.2. Bargaining Power of Suppliers |
|
|
4.5.3. Threat of New Entrants |
|
|
4.5.4. Threat of Substitute
Products |
|
|
4.5.5. Intensity of Competitive
Rivalry |
|
|
4.6. Competitive Metric Space Analysis |
|
|
Chapter
5. Clinical Trial Supplies Market, By Services (Market Size and Forecast
by Value - USD Million, 2020 - 2030) |
|
|
5.1. Clinical Trial Supplies Market, By
Services (Market Size and Forecast by Value - USD Million, 2022 & 2030) |
|
|
5.1.1. Logistics &
distribution |
|
|
5.1.1.1. Logistics & distribution Market
Estimates and Forecast, 2020-2030 (USD Million) |
|
|
5.1.1.2. Logistics & distribution Market
Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
|
5.1.2. Storage & retention |
|
|
5.1.2.1. Storage & retention
Market Estimates and Forecast, 2020-2030 (USD Million) |
|
|
5.1.2.2. Storage
& retention Market Estimates and Forecast, By Region, 2020-2030 (USD
Million) |
|
|
5.1.3. Packaging, labelling,
and blinding |
|
|
5.1.3.1. Packaging,
labelling, and blinding Market Estimates and Forecast, 2020-2030 (USD
Million) |
|
|
5.1.3.2. Packaging,
labelling, and blinding Market Estimates and Forecast, By Region, 2020-2030
(USD Million) |
|
|
5.1.4. Manufacturing |
|
|
5.1.4.1.
Manufacturing Market Estimates and Forecast, 2020-2030 (USD Million) |
|
|
5.1.4.2.
Manufacturing Market Estimates and Forecast, By Region, 2020-2030 (USD
Million) |
|
|
5.1.5. Comparator sourcing |
|
|
5.1.5.1. Comparator
sourcing Market Estimates and Forecast, 2020-2030 (USD Million) |
|
|
5.1.5.2. Comparator
sourcing Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
|
5.1.6. Other services
(solutions, ancillary supply) |
|
|
5.1.6.1. Other
services (solutions, ancillary supply) Market Estimates and Forecast,
2020-2030 (USD Million) |
|
|
5.1.6.2. Other
services (solutions, ancillary supply) Market Estimates and Forecast, By
Region, 2020-2030 (USD Million) |
|
|
Chapter
6. Clinical Trial Supplies Market, By Phase (Market Size and Forecast by
Value - USD Million, 2020 - 2030) |
|
|
6.1. Clinical Trial Supplies Market, By
Phase (Market Size and Forecast by Value - USD Million, 2022 & 2030) |
|
|
6.1.1. Phase 1 |
|
|
6.1.1.1. Phase 1 Market Estimates and Forecast,
2020-2030 (USD Million) |
|
|
6.1.1.2. Phase 1 Market Estimates and Forecast, By
Region, 2020-2030 (USD Million) |
|
|
6.1.2. Phase 2 |
|
|
6.1.2.1. Phase 2 Market Estimates and Forecast,
2020-2030 (USD Million) |
|
|
6.1.2.2. Phase 2 Market Estimates and Forecast, By
Region, 2020-2030 (USD Million) |
|
|
6.1.3. Phase 3 |
|
|
6.1.3.1. Phase 3 Market Estimates
and Forecast, 2020-2030 (USD Million) |
|
|
6.1.3.2. Phase 3
Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
|
6.1.4. Phase 4 |
|
|
6.1.4.1. Phase 4
Market Estimates and Forecast, 2020-2030 (USD Million) |
|
|
6.1.4.2. Phase 4
Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
|
6.1.5. BA/ BE studies |
|
|
6.1.5.1. BA/ BE
studies Market Estimates and Forecast, 2020-2030 (USD Million) |
|
|
6.1.5.2. BA/ BE
studies Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
|
Chapter
7. Clinical Trial Supplies Market, By Type (Market Size and Forecast by
Value - USD Million, 2020 - 2030) |
|
|
7.1. Clinical Trial Supplies Market, By
Type (Market Size and Forecast by Value - USD Million, 2022 & 2030) |
|
|
7.1.1. Small-molecules |
|
|
7.1.1.1. Small-molecules Market Estimates and
Forecast, 2020-2030 (USD Million) |
|
|
7.1.1.2. Small-molecules Market Estimates and
Forecast, By Region, 2020-2030 (USD Million) |
|
|
7.1.2. Biologic drugs |
|
|
7.1.2.1. Biologic drugs Market Estimates and
Forecast, 2020-2030 (USD Million) |
|
|
7.1.2.2. Biologic drugs Market Estimates and
Forecast, By Region, 2020-2030 (USD Million) |
|
|
7.1.3. Medical devices |
|
|
7.1.3.1. Medical
devices Market Estimates and Forecast, 2020-2030 (USD Million) |
|
|
7.1.3.2. Medical
devices Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
|
Chapter 8. Clinical
Trial Supplies Market, By Therapeutic Area (Market Size and Forecast by Value
- USD Million, 2020 - 2030) |
|
|
8.1. Clinical Trial Supplies Market, By
Therapeutic Area (Market Size and Forecast by Value - USD Million, 2022 &
2030) |
|
|
8.1.1. Oncology |
|
|
8.1.1.1. Oncology Market Estimates and Forecast,
2020-2030 (USD Million) |
|
|
8.1.1.2. Oncology Market Estimates and Forecast, By
Region, 2020-2030 (USD Million) |
|
|
8.1.2. CNS and mental disorders |
|
|
8.1.2.1. CNS and mental disorders Market Estimates
and Forecast, 2020-2030 (USD Million) |
|
|
8.1.2.2. CNS and mental disorders Market Estimates
and Forecast, By Region, 2020-2030 (USD Million) |
|
|
8.1.3. Cardiovascular diseases |
|
|
8.1.3.1.
Cardiovascular diseases Market Estimates and Forecast, 2020-2030 (USD
Million) |
|
|
8.1.3.2.
Cardiovascular diseases Market Estimates and Forecast, By Region, 2020-2030
(USD Million) |
|
|
8.1.4. Digestive disorders |
|
|
8.1.4.1. Digestive
disorders Market Estimates and Forecast, 2020-2030 (USD Million) |
|
|
8.1.4.2. Digestive
disorders Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
|
8.1.5. Infectious diseases |
|
|
8.1.5.1. Infectious diseases Market Estimates and
Forecast, 2020-2030 (USD Million) |
|
|
8.1.5.2. Infectious diseases Market Estimates and
Forecast, By Region, 2020-2030 (USD Million) |
|
|
8.1.6. Metabolic disorders |
|
|
8.1.6.1. Metabolic
disorders Market Estimates and Forecast, 2020-2030 (USD Million) |
|
|
8.1.6.2. Metabolic
disorders Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
|
8.1.7. Immunology |
|
|
8.1.7.1. Immunology
Market Estimates and Forecast, 2020-2030 (USD Million) |
|
|
8.1.7.2. Immunology
Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
|
8.1.8. Blood disorders |
|
|
8.1.8.1. Blood
disorders Market Estimates and Forecast, 2020-2030 (USD Million) |
|
|
8.1.8.2. Blood
disorders Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
|
8.1.9. Other therapeutic areas |
|
|
8.1.9.1. Other
therapeutic areas Market Estimates and Forecast, 2020-2030 (USD Million) |
|
|
8.1.9.2. Other
therapeutic areas Market Estimates and Forecast, By Region, 2020-2030 (USD
Million) |
|
|
Chapter
9. Clinical Trial Supplies Market, By End User (Market Size and Forecast
by Value - USD Million, 2020 - 2030) |
|
|
9.1. Clinical Trial Supplies Market, By
End User (Market Size and Forecast by Value - USD Million, 2022 & 2030) |
|
|
9.1.1. Pharmaceutical &
Biotechnology companies |
|
|
9.1.1.1. Pharmaceutical & Biotechnology
companies Market Estimates and Forecast, 2020-2030 (USD Million) |
|
|
9.1.1.2. Pharmaceutical & Biotechnology
companies Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
|
9.1.2. Contract Research
Organisations (CROs) |
|
|
9.1.2.1. Contract Research Organisations (CROs)
Market Estimates and Forecast, 2020-2030 (USD Million) |
|
|
9.1.2.2. Contract Research Organisations (CROs)
Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
|
9.1.3. Medical Devices
Companies |
|
|
9.1.3.1. Medical
Devices Companies Market Estimates and Forecast, 2020-2030 (USD Million) |
|
|
9.1.3.2. Medical
Devices Companies Market Estimates and Forecast, By Region, 2020-2030 (USD
Million) |
|
|
9.1.4. Academia |
|
|
9.1.4.1. Academia
Market Estimates and Forecast, 2020-2030 (USD Million) |
|
|
9.1.4.2. Academia
Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
|
9.1.5. Investigators |
|
|
9.1.5.1. Investigators Market
Estimates and Forecast, 2020-2030 (USD Million) |
|
|
9.1.5.2.
Investigators Market Estimates and Forecast, By Region, 2020-2030 (USD
Million) |
|
|
9.1.6. Regulators |
|
|
9.1.6.1. Regulators Market
Estimates and Forecast, 2020-2030 (USD Million) |
|
|
9.1.6.2. Regulators
Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
|
9.1.7. Ethics/IRBs |
|
|
9.1.7.1. Ethics/IRBs
Market Estimates and Forecast, 2020-2030 (USD Million) |
|
|
9.1.7.2. Ethics/IRBs
Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
|
9.1.8. Participants |
|
|
9.1.8.1. Participants
Market Estimates and Forecast, 2020-2030 (USD Million) |
|
|
9.1.8.2.
Participants Market Estimates and Forecast, By Region, 2020-2030 (USD
Million) |
|
|
9.1.9. Data/Tech |
|
|
9.1.9.1. Data/Tech Market
Estimates and Forecast, 2020-2030 (USD Million) |
|
|
9.1.9.2. Data/Tech
Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
|
9.1.10. Logistics |
|
|
9.1.10.1. Logistics
Market Estimates and Forecast, 2020-2030 (USD Million) |
|
|
9.1.10.2. Logistics
Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
|
Chapter
10. Clinical Trial Supplies Market, By Region (Market Size and Forecast by
Value - USD Million, 2020 - 2030) |
|
|
10.1. Clinical Trial Supplies Market,
By Region (Market Size and Forecast by Value - USD Million, 2022 & 2030) |
|
|
10.2. North America |
|
|
10.2.1. North America Clinical
Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
|
10.2.2. North America Clinical
Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
|
10.2.3. North America Clinical
Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
|
10.2.4. North America Clinical
Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD Million) |
|
|
10.2.5. North America Clinical
Trial Supplies Market, By End User, 2020-2030 (USD Million) |
|
|
10.2.6. North America Clinical
Trial Supplies Market, By Country, 2020-2030 (USD Million) |
|
|
10.2.7. U.S. |
|
|
10.2.7.1. U.S.
Clinical Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
|
10.2.7.2. U.S.
Clinical Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
|
10.2.7.3. U.S.
Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
|
10.2.7.4. U.S.
Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD Million) |
|
|
10.2.7.5. U.S.
Clinical Trial Supplies Market, By End User, 2020-2030 (USD Million) |
|
|
10.2.8. Canada |
|
|
10.2.8.1. Canada
Clinical Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
|
10.2.8.2. Canada
Clinical Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
|
10.2.8.3. Canada
Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
|
10.2.8.4. Canada
Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD Million) |
|
|
10.2.8.5. Canada
Clinical Trial Supplies Market, By End User, 2020-2030 (USD Million) |
|
|
10.3. Europe |
|
|
10.3.1. Europe Clinical Trial
Supplies Market, By Services, 2020-2030 (USD Million) |
|
|
10.3.2. Europe Clinical Trial
Supplies Market, By Phase, 2020-2030 (USD Million) |
|
|
10.3.3. Europe Clinical Trial
Supplies Market, By Type, 2020-2030 (USD Million) |
|
|
10.3.4. Europe Clinical Trial
Supplies Market, By Therapeutic Area, 2020-2030 (USD Million) |
|
|
10.3.5. Europe Clinical Trial
Supplies Market, By End User, 2020-2030 (USD Million) |
|
|
10.3.6. Europe Clinical Trial
Supplies Market, By Country, 2020-2030 (USD Million) |
|
|
10.3.7. Germany |
|
|
10.3.7.1. Germany
Clinical Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
|
10.3.7.2. Germany
Clinical Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
|
10.3.7.3. Germany
Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
|
10.3.7.4. Germany
Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD Million) |
|
|
10.3.7.5. Germany
Clinical Trial Supplies Market, By End User, 2020-2030 (USD Million) |
|
|
10.3.8. U.K. |
|
|
10.3.8.1. U.K.
Clinical Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
|
10.3.8.2. U.K.
Clinical Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
|
10.3.8.3. U.K.
Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
|
10.3.8.4. U.K.
Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD Million) |
|
|
10.3.8.5. U.K.
Clinical Trial Supplies Market, By End User, 2020-2030 (USD Million) |
|
|
10.3.9. France |
|
|
10.3.9.1. France
Clinical Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
|
10.3.9.2. France
Clinical Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
|
10.3.9.3. France
Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
|
10.3.9.4. France
Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD Million) |
|
|
10.3.9.5. France
Clinical Trial Supplies Market, By End User, 2020-2030 (USD Million) |
|
|
10.3.10. Spain |
|
|
10.3.10.1. Spain
Clinical Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
|
10.3.10.2. Spain
Clinical Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
|
10.3.10.3. Spain Clinical Trial
Supplies Market, By Type, 2020-2030 (USD Million) |
|
|
10.3.10.4. Spain
Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD Million) |
|
|
10.3.10.5. Spain
Clinical Trial Supplies Market, By End User, 2020-2030 (USD Million) |
|
|
10.3.11. Italy |
|
|
10.3.11.1. Italy
Clinical Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
|
10.3.11.2. Italy
Clinical Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
|
10.3.11.3. Italy
Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
|
10.3.11.4. Italy
Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD Million) |
|
|
10.3.11.5. Italy
Clinical Trial Supplies Market, By End User, 2020-2030 (USD Million) |
|
|
10.3.12. Rest of Europe |
|
|
10.3.12.1. Rest of Europe
Clinical Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
|
10.3.12.2. Rest
of Europe Clinical Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
|
10.3.12.3. Rest
of Europe Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
|
10.3.12.4. Rest
of Europe Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD
Million) |
|
|
10.3.12.5. Rest of
Europe Clinical Trial Supplies Market, By End User, 2020-2030 (USD Million) |
|
|
10.4. Asia Pacific |
|
|
10.4.1. Asia Pacific Clinical
Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
|
10.4.2. Asia Pacific Clinical
Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
|
10.4.3. Asia Pacific Clinical
Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
|
10.4.4. Asia Pacific Clinical
Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD Million) |
|
|
10.5.5. Asia Pacific Clinical
Trial Supplies Market, By End User, 2020-2030 (USD Million) |
|
|
10.4.6. Asia Pacific Clinical
Trial Supplies Market, By Country, 2020-2030 (USD Million) |
|
|
10.4.7. India |
|
|
10.4.7.1. India
Clinical Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
|
10.4.7.2. India
Clinical Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
|
10.4.7.3. India
Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
|
10.4.7.4. India
Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD Million) |
|
|
10.5.7.5. India
Clinical Trial Supplies Market, By End User, 2020-2030 (USD Million) |
|
|
10.4.8. Japan |
|
|
10.4.8.1. Japan
Clinical Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
|
10.4.8.2. Japan
Clinical Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
|
10.4.8.3. Japan
Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
|
10.4.8.4. Japan
Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD Million) |
|
|
10.5.8.5. Japan
Clinical Trial Supplies Market, By End User, 2020-2030 (USD Million) |
|
|
10.4.9. China |
|
|
10.4.9.1. China
Clinical Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
|
10.4.9.2. China
Clinical Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
|
10.4.9.3. China
Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
|
10.4.9.4. China
Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD Million) |
|
|
10.5.10.5. China
Clinical Trial Supplies Market, By End User, 2020-2030 (USD Million) |
|
|
10.4.10. South Korea |
|
|
10.4.10.1. South
Korea Clinical Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
|
10.4.10.2. South
Korea Clinical Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
|
10.4.10.3. South
Korea Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
|
10.4.10.4. South Korea
Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD Million) |
|
|
10.5.10.5. South
Korea Clinical Trial Supplies Market, By End User, 2020-2030 (USD Million) |
|
|
10.4.11. Australia |
|
|
10.4.11.1.
Australia Clinical Trial Supplies Market, By Services, 2020-2030 (USD
Million) |
|
|
10.4.11.2.
Australia Clinical Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
|
10.4.11.3.
Australia Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
|
10.4.11.4.
Australia Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD
Million) |
|
|
10.5.11.5.
Australia Clinical Trial Supplies Market, By End User, 2020-2030 (USD
Million) |
|
|
10.4.12. Rest of Asia Pacific |
|
|
10.4.12.1. Rest
of Asia Pacific Clinical Trial Supplies Market, By Services, 2020-2030 (USD
Million) |
|
|
10.4.12.2. Rest
of Asia Pacific Clinical Trial Supplies Market, By Phase, 2020-2030 (USD
Million) |
|
|
10.4.12.3. Rest
of Asia Pacific Clinical Trial Supplies Market, By Type, 2020-2030 (USD
Million) |
|
|
10.4.12.4. Rest
of Asia Pacific Clinical Trial Supplies Market, By Therapeutic Area,
2020-2030 (USD Million) |
|
|
10.5.12.5. Rest
of Asia Pacific Clinical Trial Supplies Market, By End User, 2020-2030 (USD
Million) |
|
|
10.5. Middle East & Africa |
|
|
10.5.1. Middle East &
Africa Clinical Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
|
10.5.2. Middle East &
Africa Clinical Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
|
10.5.3. Middle East &
Africa Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
|
10.5.4. Middle East &
Africa Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD
Million) |
|
|
10.5.5. Middle East &
Africa Clinical Trial Supplies Market, By End User, 2020-2030 (USD Million) |
|
|
10.5.6. Middle East &
Africa Clinical Trial Supplies Market, By Country, 2020-2030 (USD Million) |
|
|
10.5.7. UAE |
|
|
10.5.7.1. UAE
Clinical Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
|
10.5.7.2. UAE Clinical
Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
|
10.5.7.3. UAE
Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
|
10.5.7.4. UAE Clinical
Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD Million) |
|
|
10.5.7.5. UAE
Clinical Trial Supplies Market, By End User, 2020-2030 (USD Million) |
|
|
10.5.8. Saudi Arabia |
|
|
10.5.8.1. Saudi
Arabia Clinical Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
|
10.5.8.2. Saudi
Arabia Clinical Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
|
10.5.8.3. Saudi
Arabia Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
|
10.5.8.4. Saudi
Arabia Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD
Million) |
|
|
10.5.8.5. Saudi
Arabia Clinical Trial Supplies Market, By End User, 2020-2030 (USD Million) |
|
|
10.5.9. South Africa |
|
|
10.5.9.1. South
Africa Clinical Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
|
10.5.9.2. South
Africa Clinical Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
|
10.5.9.3. South
Africa Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
|
10.5.9.4. South
Africa Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD
Million) |
|
|
10.5.9.5. South
Africa Clinical Trial Supplies Market, By End User, 2020-2030 (USD Million) |
|
|
10.5.10. Rest of Middle East &
Africa |
|
|
10.5.10.1. Rest
of Middle East & Africa Clinical Trial Supplies Market, By Services,
2020-2030 (USD Million) |
|
|
10.5.10.2. Rest
of Middle East & Africa Clinical Trial Supplies Market, By Phase,
2020-2030 (USD Million) |
|
|
10.5.10.3. Rest
of Middle East & Africa Clinical Trial Supplies Market, By Type,
2020-2030 (USD Million) |
|
|
10.5.10.4. Rest
of Middle East & Africa Clinical Trial Supplies Market, By Therapeutic
Area, 2020-2030 (USD Million) |
|
|
10.5.10.5. Rest
of Middle East & Africa Clinical Trial Supplies Market, By End User,
2020-2030 (USD Million) |
|
|
10.6. Latin America |
|
|
10.6.1. Latin America Clinical
Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
|
10.6.2. Latin America Clinical
Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
|
10.6.3. Latin America Clinical
Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
|
10.6.4. Latin America Clinical
Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD Million) |
|
|
10.6.5. Latin America Clinical
Trial Supplies Market, By End User, 2020-2030 (USD Million) |
|
|
10.6.6. Latin America Clinical
Trial Supplies Market, By Country, 2020-2030 (USD Million) |
|
|
10.6.7. Brazil |
|
|
10.6.7.1. Brazil
Clinical Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
|
10.6.7.2. Brazil
Clinical Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
|
10.6.7.3. Brazil
Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
|
10.6.7.4. Brazil
Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD Million) |
|
|
10.6.7.5. Brazil
Clinical Trial Supplies Market, By End User, 2020-2030 (USD Million) |
|
|
10.6.8. Mexico |
|
|
10.6.8.1. Mexico Clinical Trial
Supplies Market, By Services, 2020-2030 (USD Million) |
|
|
10.6.8.2. Mexico
Clinical Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
|
10.6.8.3. Mexico
Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
|
10.6.8.4. Mexico
Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD Million) |
|
|
10.6.8.5. Mexico Clinical Trial
Supplies Market, By End User, 2020-2030 (USD Million) |
|
|
10.6.9. Argentina |
|
|
10.6.9.1.
Argentina Clinical Trial Supplies Market, By Services, 2020-2030 (USD
Million) |
|
|
10.6.9.2. Argentina Clinical
Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
|
10.6.9.3.
Argentina Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
|
10.6.9.4. Argentina
Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD Million) |
|
|
10.6.9.5.
Argentina Clinical Trial Supplies Market, By End User, 2020-2030 (USD
Million) |
|
|
10.6.10. Rest of Latin America |
|
|
10.6.10.1. Rest
of Latin America Clinical Trial Supplies Market, By Services, 2020-2030 (USD
Million) |
|
|
10.6.10.2. Rest
of Latin America Clinical Trial Supplies Market, By Phase, 2020-2030 (USD
Million) |
|
|
10.6.10.3. Rest
of Latin America Clinical Trial Supplies Market, By Type, 2020-2030 (USD
Million) |
|
|
10.6.10.4. Rest
of Latin America Clinical Trial Supplies Market, By Therapeutic Area,
2020-2030 (USD Million) |
|
|
10.6.10.5. Rest
of Latin America Clinical Trial Supplies Market, By End User, 2020-2030 (USD
Million) |
|
|
Chapter
11. Competitive Landscape |
|
|
11.1. Market Revenue Share by
Manufacturers |
|
|
11.2. Competitor’s Positioning |
|
|
11.3. Strategy Benchmarking |
|
|
11.3.1. Partnership &
Agreement |
|
|
11.3.2. New Product
Development |
|
|
11.3.3. Mergers &
Acquisitions |
|
|
11.3.4. Investment &
Expansion |
|
|
11.4. Vendor Landscape |
|
|
11.4.1. Distributors |
|
|
11.4.2. North America |
|
|
11.4.3. Europe |
|
|
11.4.4. Asia Pacific |
|
|
11.4.5. Middle East &
Africa |
|
|
11.4.6. Latin America |
|
|
11.5. Zettabyte Analytics Insights for
Competitive Landscape |
|
|
Chapter
12. Company Profiles |
|
|
12.1. Acnos Pharma Gmbh |
|
|
12.1.1. Company Overview |
|
|
12.1.2. Products Offered |
|
|
12.1.3. Financials |
|
|
12.1.4. Recent
Development |
|
|
12.2. Adallen Pharma |
|
|
12.2.1. Company Overview |
|
|
12.2.2. Products Offered |
|
|
12.2.3. Financials |
|
|
12.2.4. Recent
Development |
|
|
12.3. Almac Group |
|
|
12.3.1. Company Overview |
|
|
12.3.2. Products Offered |
|
|
12.3.3. Financials |
|
|
12.3.4. Recent
Development |
|
|
12.4. Ancillare, Lp |
|
|
12.4.1. Company Overview |
|
|
12.4.2. Products Offered |
|
|
12.4.3. Financials |
|
|
12.4.4. Recent
Development |
|
|
12.5. Biocair |
|
|
12.5.1. Company Overview |
|
|
12.5.2. Products Offered |
|
|
12.5.3. Financials |
|
|
12.5.4. Recent
Development |
|
|
12.6. Capsugel (Acquired By Lonza) |
|
|
12.6.1. Company Overview |
|
|
12.6.2. Products Offered |
|
|
12.6.3. Financials |
|
|
12.6.4. Recent
Development |
|
|
12.7. Catalent, Inc. |
|
|
12.7.1. Company Overview |
|
|
12.7.2. Products Offered |
|
|
12.7.3. Financials |
|
|
12.7.4. Recent
Development |
|
|
12.8. Clinical Services International |
|
|
12.8.1. Company Overview |
|
|
12.8.2. Products Offered |
|
|
12.8.3. Financials |
|
|
12.8.4. Recent
Development |
|
|
12.9. Clinigen Limited |
|
|
12.9.1. Company Overview |
|
|
12.9.2. Products Offered |
|
|
12.9.3. Financials |
|
|
12.9.4. Recent
Development |
|
|
12.10. Corex Logistics |
|
|
12.10.1. Company Overview |
|
|
12.10.2. Products Offered |
|
|
12.10.3. Financials |
|
|
12.10.4. Recent
Development |
|
|
12.11. Ct Group LLC |
|
|
12.11.1. Company Overview |
|
|
12.11.2. Products Offered |
|
|
12.11.3. Financials |
|
|
12.11.4. Recent
Development |
|
|
12.12. Durbin |
|
|
12.12.1. Company Overview |
|
|
12.12.2. Products Offered |
|
|
12.12.3. Financials |
|
|
12.12.4. Recent Development |
|
|
12.13. Eurofins Scientific |
|
|
12.13.1. Company Overview |
|
|
12.13.2. Products Offered |
|
|
12.13.3. Financials |
|
|
12.13.4. Recent
Development |
|
|
12.14. Infosys |
|
|
12.14.1. Company Overview |
|
|
12.14.2. Products Offered |
|
|
12.14.3. Financials |
|
|
12.14.4. Recent
Development |
|
|
12.15. Klifo |
|
|
12.15.1. Company Overview |
|
|
12.15.2. Products Offered |
|
|
12.15.3. Financials |
|
|
12.15.4. Recent
Development |
|
|
12.16. Liveo Research |
|
|
12.16.1. Company Overview |
|
|
12.16.2. Products Offered |
|
|
12.16.3. Financials |
|
|
12.16.4. Recent
Development |
|
|
12.17. Marken (Subsidiary Of Ups) |
|
|
12.17.1. Company Overview |
|
|
12.17.2. Products Offered |
|
|
12.17.3. Financials |
|
|
12.17.4. Recent
Development |
|
|
12.18. Movianto |
|
|
12.18.1. Company Overview |
|
|
12.18.2. Products Offered |
|
|
12.18.3. Financials |
|
|
12.18.4. Recent Development |
|
|
12.19. N-Side |
|
|
12.19.1. Company Overview |
|
|
12.19.2. Products Offered |
|
|
12.19.3. Financials |
|
|
12.19.4. Recent
Development |
|
|
12.20. Parexel International Corporation |
|
|
12.20.1. Company Overview |
|
|
12.20.2. Products Offered |
|
|
12.20.3. Financials |
|
|
12.20.4. Recent
Development |
|
|
12.21. Pci Pharma Services |
|
|
12.21.1. Company Overview |
|
|
12.21.2. Products Offered |
|
|
12.21.3. Financials |
|
|
12.21.4. Recent
Development |
|
|
12.22. Piramal Pharma Solutions |
|
|
12.22.1. Company Overview |
|
|
12.22.2. Products Offered |
|
|
12.22.3. Financials |
|
|
12.22.4. Recent
Development |
|
|
12.23. Pra Health Sciences (Subsidiary
Of Icon Plc) |
|
|
12.23.1. Company Overview |
|
|
12.23.2. Products Offered |
|
|
12.23.3. Financials |
|
|
12.23.4. Recent
Development |
|
|
12.24. Recipharm Ab |
|
|
12.24.1. Company Overview |
|
|
12.24.2. Products Offered |
|
|
12.24.3. Financials |
|
|
12.24.4. Recent
Development |
|
|
12.25. Thermo Fisher Scientific |
|
|
12.25.1. Company Overview |
|
|
12.25.2. Products Offered |
|
|
12.25.3. Financials |
|
|
12.25.4. Recent
Development |
|
|
Chapter
13. Research Methodology |
|
|
13.1. Research Sources |
|
|
13.1.1. Primary |
|
|
13.1.2. Secondary |
|
|
13.2. Market Size Estimation |
|
|
Chapter
14. Appendix |
|
|
14.1.
Discussion guide |
|
|
14.2.
Knowledge Store: Zettabyte Analytics Subscription Portal |
|
|
14.3.
Available Customizations |
|
|
14.4.
Associated Zettabyte Analytics Reports |
|
|
List of
Tables |
|
|
Table 1 |
Clinical
Trial Supplies Market, By Services (Market Size and Forecast by Value - USD
Million, 2022 & 2030) |
|
Table 2 |
Logistics
& distribution Market Estimates and Forecast, 2020-2030 (USD Million) |
|
Table 3 |
Logistics
& distribution Market Estimates and Forecast, By Region, 2020-2030 (USD
Million) |
|
Table 4 |
Storage
& retention Market Estimates and Forecast, 2020-2030 (USD Million) |
|
Table 5 |
Storage
& retention Market Estimates and Forecast, By Region, 2020-2030 (USD
Million) |
|
Table 6 |
Clinical
Trial Supplies Market, By Phase (Market Size and Forecast by Value - USD
Million, 2022 & 2030) |
|
Table 7 |
Phase 1
Market Estimates and Forecast, 2020-2030 (USD Million) |
|
Table 8 |
Phase 1
Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
Table 9 |
Clinical
Trial Supplies Market, By Type (Market Size and Forecast by Value - USD
Million, 2022 & 2030) |
|
Table 10 |
Small-molecules
Market Estimates and Forecast, 2020-2030 (USD Million) |
|
Table 11 |
Small-molecules
Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
Table 12 |
Biologic
drugs Market Estimates and Forecast, 2020-2030 (USD Million) |
|
Table 13 |
Biologic
drugs Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
Table 14 |
Medical
devices Market Estimates and Forecast, 2020-2030 (USD Million) |
|
Table 15 |
Medical
devices Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
Table 16 |
Clinical
Trial Supplies Market, By Therapeutic Area (Market Size and Forecast by Value
- USD Million, 2022 & 2030) |
|
Table 17 |
Oncology
Market Estimates and Forecast, 2020-2030 (USD Million) |
|
Table 18 |
Oncology
Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
Table 19 |
CNS and
mental disorders Market Estimates and Forecast, 2020-2030 (USD Million) |
|
Table 20 |
CNS and mental
disorders Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
Table 21 |
North
America Clinical Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
Table 22 |
North
America Clinical Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
Table 23 |
North
America Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
Table 24 |
North
America Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD
Million) |
|
Table 25 |
North
America Clinical Trial Supplies Market, By Country, 2020-2030 (USD Million) |
|
Table 26 |
U.S.
Clinical Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
Table 27 |
U.S.
Clinical Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
Table 28 |
U.S.
Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
Table 29 |
U.S.
Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD Million) |
|
Table 30 |
Canada
Clinical Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
Table 31 |
Canada
Clinical Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
Table 32 |
Canada
Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
Table 33 |
Canada
Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD Million) |
|
Table 34 |
Europe
Clinical Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
Table 35 |
Europe
Clinical Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
Table 40 |
Europe
Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
Table 37 |
Europe Clinical
Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD Million) |
|
Table 38 |
Europe
Clinical Trial Supplies Market, By Country, 2020-2030 (USD Million) |
|
Table 39 |
Germany
Clinical Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
Table 40 |
Germany
Clinical Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
Table 41 |
Germany
Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
Table 42 |
Germany
Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD Million) |
|
Table 43 |
U.K.
Clinical Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
Table 44 |
U.K.
Clinical Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
Table 45 |
U.K.
Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
Table 46 |
U.K.
Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD Million) |
|
Table 47 |
France
Clinical Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
Table 48 |
France
Clinical Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
Table 49 |
France
Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
Table 50 |
France
Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD Million) |
|
Table 51 |
Spain
Clinical Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
Table 52 |
Spain
Clinical Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
Table 53 |
Spain
Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
Table 54 |
Spain
Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD Million) |
|
Table 55 |
Italy
Clinical Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
Table 56 |
Italy
Clinical Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
Table 57 |
Italy
Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
Table 58 |
Italy
Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD Million) |
|
Table 59 |
Rest of
Europe Clinical Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
Table 60 |
Rest of
Europe Clinical Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
Table 61 |
Rest of
Europe Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
Table 62 |
Rest of
Europe Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD
Million) |
|
Table 63 |
Asia
Pacific Clinical Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
Table 64 |
Asia
Pacific Clinical Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
Table 65 |
Asia
Pacific Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
Table 66 |
Asia
Pacific Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD
Million) |
|
Table 67 |
Asia
Pacific Clinical Trial Supplies Market, By Country, 2020-2030 (USD Million) |
|
Table 68 |
India
Clinical Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
Table 69 |
India
Clinical Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
Table 70 |
India
Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
Table 71 |
India
Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD Million) |
|
Table 72 |
Japan
Clinical Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
Table 73 |
Japan
Clinical Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
Table 74 |
Japan
Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
Table 75 |
Japan
Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD Million) |
|
Table 76 |
China
Clinical Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
Table 77 |
China
Clinical Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
Table 78 |
China
Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
Table 79 |
China
Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD Million) |
|
Table 80 |
South
Korea Clinical Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
Table 81 |
South
Korea Clinical Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
Table 82 |
South
Korea Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
Table 83 |
South Korea
Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD Million) |
|
Table 84 |
Australia
Clinical Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
Table 85 |
Australia
Clinical Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
Table 86 |
Australia
Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
Table 87 |
Australia
Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD Million) |
|
Table 88 |
Rest of
Asia Pacific Clinical Trial Supplies Market, By Services, 2020-2030 (USD
Million) |
|
Table 89 |
Rest of
Asia Pacific Clinical Trial Supplies Market, By Phase, 2020-2030 (USD
Million) |
|
Table 90 |
Rest of
Asia Pacific Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
Table 91 |
Rest of
Asia Pacific Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030
(USD Million) |
|
Table 92 |
Middle
East & Africa Clinical Trial Supplies Market, By Services, 2020-2030 (USD
Million) |
|
Table 93 |
Middle
East & AfricaClinical Trial Supplies Market, By Phase, 2020-2030 (USD
Million) |
|
Table 94 |
Middle
East & Africa Clinical Trial Supplies Market, By Type, 2020-2030 (USD
Million) |
|
Table 95 |
Middle
East & Africa Clinical Trial Supplies Market, By Therapeutic Area,
2020-2030 (USD Million) |
|
Table 96 |
Middle
East & Africa Clinical Trial Supplies Market, By Country, 2020-2030 (USD
Million) |
|
Table 97 |
UAE
Clinical Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
Table 98 |
UAE
Clinical Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
Table 99 |
UAE Clinical
Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
Table 100 |
UAE
Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD Million) |
|
Table 101 |
Saudi
Arabia Clinical Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
Table 102 |
Saudi
Arabia Clinical Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
Table 103 |
Saudi
Arabia Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
Table 104 |
Saudi
Arabia Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD
Million) |
|
Table 105 |
South
Africa Clinical Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
Table 106 |
South
Africa Clinical Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
Table 107 |
South
Africa Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
Table 108 |
South
Africa Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD
Million) |
|
Table 109 |
Rest of
Middle East & Africa Clinical Trial Supplies Market, By Services,
2020-2030 (USD Million) |
|
Table 110 |
Rest of
Middle East & Africa Clinical Trial Supplies Market, By Phase, 2020-2030
(USD Million) |
|
Table 111 |
Rest of
Middle East & Africa Clinical Trial Supplies Market, By Type, 2020-2030
(USD Million) |
|
Table 112 |
Rest of
Middle East & Africa Clinical Trial Supplies Market, By Therapeutic Area,
2020-2030 (USD Million) |
|
Table 113 |
Latin
America Clinical Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
Table 114 |
Latin
America Clinical Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
Table 115 |
Latin
America Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
Table 116 |
Latin
America Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD
Million) |
|
Table 117 |
Latin
America Clinical Trial Supplies Market, By Country, 2020-2030 (USD Million) |
|
Table 118 |
Brazil
Clinical Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
Table 119 |
Brazil
Clinical Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
Table 120 |
Brazil
Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
Table 121 |
Brazil
Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD Million) |
|
Table 122 |
Mexico
Clinical Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
Table 123 |
Mexico Clinical
Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
Table 124 |
Mexico
Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
Table 125 |
Mexico
Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD Million) |
|
Table 126 |
Argentina
Clinical Trial Supplies Market, By Services, 2020-2030 (USD Million) |
|
Table 127 |
Argentina
Clinical Trial Supplies Market, By Phase, 2020-2030 (USD Million) |
|
Table 128 |
Argentina
Clinical Trial Supplies Market, By Type, 2020-2030 (USD Million) |
|
Table 129 |
Argentina
Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030 (USD Million) |
|
Table 130 |
Rest of
Latin America Clinical Trial Supplies Market, By Services, 2020-2030 (USD
Million) |
|
Table 131 |
Rest of
Latin America Clinical Trial Supplies Market, By Phase, 2020-2030 (USD
Million) |
|
Table 132 |
Rest of
Latin America Clinical Trial Supplies Market, By Type, 2020-2030 (USD
Million) |
|
Table 133 |
Rest of
Latin America Clinical Trial Supplies Market, By Therapeutic Area, 2020-2030
(USD Million) |
|
Table 134 |
Product
Launch & Development in The Clinical Trial Supplies Market, 2018-2021 |
|
Table 135 |
Investment
and Expansion in The Clinical Trial Supplies Market, 2020-2022 |
|
Table 140 |
Partnership
& Collaboration in The Clinical Trial Supplies Market, 2020-2022 |
|
Table 137 |
Merger
& Acquisition in The Clinical Trial Supplies Market, 2020-2022 |
|
List of
Figures |
|
|
Figure 1 |
Research
Methodology |
|
Figure 2 |
Summary
Snapshot Market Size and Forecast, USD Million, 2022 & 2030 |
|
Figure 3 |
Global Clinical
Trial Supplies Market Segmentation & Impact Analysis |
|
Figure 4 |
Regulatory
Analysis |
|
Figure 5 |
COVID-19
Impact analysis on Clinical Trial Supplies Market |
|
Figure 6 |
Market
Revenue Share by Manufacturers |
|
Figure 7 |
Clinical
Trial Supplies Market, By Services (Market Size and Forecast by Value - USD
Million, 2022 & 2030) |
|
Figure 8 |
Clinical
Trial Supplies Market, By Phase (Market Size and Forecast by Value - USD
Million, 2022 & 2030) |
|
Figure 9 |
Clinical
Trial Supplies Market, By Type (Market Size and Forecast by Value - USD
Million, 2022 & 2030) |
|
Figure 10 |
Clinical
Trial Supplies Market, By Therapeutic Area (Market Size and Forecast by Value
- USD Million, 2022 & 2030) |
|
Figure 11 |
Clinical
Trial Supplies Market, By Region (Market Size and Forecast by Value - USD
Million, 2022 & 2030) |
1.
Research Sources
We at Zettabyte Analytics have a
detailed and related research methodology focussed on estimating the market
size and forecasted value for the given market. Comprehensive research
objectives and scope were obtained through secondary research of the parent and
peer markets. The next step was to validate our research by various market
models and primary research. Both top-down and bottom-up approaches were
employed to estimate the market. In addition to all the research reports, data
triangulation is one of the procedures used to evaluate the market size of
segments and sub-segments.
Research Methodology
1.1. Secondary Research
The secondary research study involves various sources and databases used
to analyze and collect information for the market-oriented survey of a specific
market. We use multiple databases for our exhaustive secondary research, such
as Factiva, Dun & Bradstreet, Bloomberg, Research article, Annual reports,
Press Release, and SEC filings of significant companies. Apart from this, a
dedicated set of teams continuously extracts data of key industry players and
makes an extensive and unique segmentation related to the latest market
development.
1.2. Primary Research
The primary research includes gathering data from specific domain
experts through a detailed questionnaire, emails, telephonic interviews, and
web-based surveys. The primary interviewees for this study include an expert
from the demand and supply side, such as CEOs, VPs, directors, sales heads, and
marketing managers of tire 1,2, and 3 companies across the globe.
1.3. Data Triangulation
The data triangulation is very important for any market study, thus we
at Zettabyte Analytics focus on at least three sources to ensure a high level
of accuracy. The data is triangulated by studying various factors and trends
from both supply and demand side. All the reports published and stored in our
repository follows a detailed process to obtain a reliable insight for our
clients.
1.4. In-House Verification
To validate the segmentation
and verify the data collected, our market expert ensures whether our research
analyst is considering fine distinction before analyzing the market.
1.5. Reporting
In the end,
presenting our research reports complied in a different format for straightforward
valuation such as ppt, pdf, and excel data pack is done.
+1 716 953 3077
sales@zettabyteanalytics.com
109 S Warren St, Syracuse, NY 13202, United States